0.0091
-0.0002
(-2.15%)
At close: January 10 at 3:08:26 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-334,981.0000
-295,500.0000
-252,198.0000
-253,818.0000
-135,830.0000
Investing Cash Flow
-95,825.0000
-80,693.0000
-67,394.0000
-73,257.0000
-67,121.0000
Financing Cash Flow
-2,168.0000
-3,216.0000
95,337.0000
1,534,145.0000
90,318.0000
End Cash Position
661,645.0000
989,584.0000
1,369,581.0000
1,592,928.0000
385,877.0000
Income Tax Paid Supplemental Data
--
670.0000
--
61.0000
--
Interest Paid Supplemental Data
--
83.0000
92.0000
2,370.0000
2,572.0000
Capital Expenditure
-52,277.0000
-40,801.0000
-52,271.0000
-56,521.0000
-57,821.0000
Issuance of Capital Stock
--
--
99,303.0000
--
91,040.0000
Repayment of Debt
-1,012.0000
-1,295.0000
-1,237.0000
-1,123.0000
-748.0000
Repurchase of Capital Stock
--
--
--
-24,998.0000
--
Free Cash Flow
-387,258.0000
-336,301.0000
-304,469.0000
-310,339.0000
-193,651.0000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALGAE.PA FERMENTALG
0.4375
+6.71%
MMIRF MedMira Inc.
0.0131
0.00%
NRXS NeurAxis, Inc.
2.4900
0.00%
CDIOW Cardio Diagnostics Holdings, Inc.
0.0780
-2.26%
EFTR eFFECTOR Therapeutics, Inc.
0.0002
0.00%
ADAG Adagene Inc.
1.9350
-1.28%
CEROW CERo Therapeutics Holdings, Inc.
0.0171
-12.31%
LVTX LAVA Therapeutics N.V.
0.9758
-5.26%
KTTA Pasithea Therapeutics Corp.
2.5600
-10.49%
FBRX Forte Biosciences, Inc.
17.78
-8.54%